Nomura Micro Science Co., Ltd. Q1 FY2027 Analysis: Strong Order Backlog Signals Future Recovery
Nomura Micro Science Co., Ltd. (TSE:6254), a leading provider of ultra-pure water systems primarily serving the semiconductor and pharmaceutical industries, reported mixed results for its first quarter (Q1) of fiscal year 2027. While the company saw significant declines in top-line revenue and profitability compared to the prior year, management provided an exceptionally bullish full-year outlook, underpinned by robust order intake suggesting a strong rebound cycle ahead.
| Metric | Current Period (JPY Xbn/M) | Prior Period (JPY Xbn/M) | YoY Change |
|---|---|---|---|
| Revenue | JPY 9.20bn | N/A | -25.8% |
| Operating Profit | JPY 628M | N/A | -54.4% |
| Ordinary Income | JPY 342M | N/A | -56.2% |
| Net Profit | JPY 239M | N/A | -48.4% |
| Operating Margin | 6.8% | N/A | N/A |
| Equity Ratio | 33.9% | 35.6% | N/A |
Nomura Micro Science Co., Ltd. specializes in advanced water purification equipment, holding a strong market position supporting critical processes within the semiconductor and pharmaceutical sectors. The company continues to expand its footprint internationally across markets such as South Korea and Taiwan.
Analysis of Quarterly Performance The Q1 results reflect a cyclical downturn, with Revenue falling 25.8% Year-over-year (YoY) and Operating Profit declining by 54.4% YoY. Management indicated that the primary drag on revenue was the conclusion of several large-scale water treatment system projects from the prior year. Although contributions from maintenance and consumables, alongside other business segments, provided some stability, the overall profitability structure appears sensitive to the timing of major capital expenditure cycles in its core markets.
However, a deeper look reveals contrasting signals. While current period revenue declined, the company reported an increase in orders received (受注高) of 783.4% YoY, signaling that future demand visibility remains exceptionally high. Furthermore, the stable contribution from recurring revenue streams like maintenance and consumables is positively impacting profitability metrics such as the Operating Margin, which remained at 6.8%.
Full-Year Guidance Management has set highly aggressive targets for the full fiscal year (FY2027), suggesting confidence in a substantial recovery trajectory following the Q1 dip.
| Metric | Full-Year Forecast (JPY Xbn/M) | YoY Change |
|---|---|---|
| Revenue | JPY 97.0bn | +72.5% |
| Operating Profit | JPY 16.0bn | +140.0% |
| Ordinary Income | JPY 15.0bn | +166.5% |
| Net Profit | JPY 11,100M | +190.7% |
The full-year forecast is notably ambitious compared to the prior year’s performance, implying that the current quarter’s weakness is viewed as a temporary cyclical dip rather than a structural decline. The substantial projected growth in both revenue and operating profit suggests management anticipates capturing significant market share or benefiting from major project completions in the latter half of FY2027.
What to Watch for Investors
- Cycle Timing vs. Order Book: International investors must differentiate between the current quarter’s realized sales (which are cyclical) and the massive increase in order intake, which serves as a strong leading indicator for future revenue realization.
- Strategic Focus Areas: The company’s commitment to its “Together Toward Transformation 26 (TTT-26)” plan—focusing on improving profitability, capital efficiency, and financial optimization—will be key to sustaining margin expansion even when large project cycles normalize.
- Semiconductor Capex Cycle: Given the strong underlying demand in advanced logic and packaging within semiconductors, monitoring global semiconductor capital expenditure trends will be crucial for validating the aggressive full-year guidance.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.